Get ready: This tiny startup could disrupt a $1.1 trillion industry

"Miracle cure" discovered: What you need to know about potentially the biggest medical breakthrough of our lifetime Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiving this email as a part of your subscription to Sure Money. To change your email settings, please see the contact information at the bottom of the email. [Sure Money] Dear Sure Money Reader, Together with one of the top venture capital experts in the country, we've uncovered something truly extraordinary. [A "holy grail" molecule that has the potential to cure millions of people suffering from some of the world's deadliest diseases](. Everything from [heart disease](... [Huntington's disease](... [Parkinson's disease](... [multiple sclerosis](... and more... Could soon be eradicated thanks to the [one privately-held cannabis startup]( we've identified for you today. In fact, it could prove to be the missing link to nearly every incurable disease known to man. And they've got the [video evidence to prove it](. It's not being covered on CNBC or in The Wall Street Journal... yet. Even now, it's so deep "under the radar," very few investors know it exists. However, today we're going to show you the only way for investors to buy private shares in this potentially $52 billion startup. Make no mistake, this is the kind of startup that could potentially turn a small investment into $1 million or more in the blink of an eye. So buckle up... because if you [click here](, you're going to see a side of the industry 99.9% of investors have never seen before... and will never see in the future. Sincerely, Mike Ward Founder, National Institute for Cannabis Investors --------------------------------------------------------------- You are receiving this e-mail at, {EMAIL}, as a part of your free subscription to Sure Money. Remove your email from this list: [Unsubscribe]( To cancel by mail or for any other subscription issues, write us at: Sure Money | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201 North America: 888.384.8339; International: 443.353.4519; Fax: 410.622.3050 [Contact Customer Service]( Website: []( © 2019 Sure Money All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Sure Money. 1125 N Charles Street, Baltimore MD 21201.